Esophageal cancer -- know the signs and reduce your risk
April is Esophageal Cancer Awareness Month, which makes this good time to learn the signs of esophageal cancer and what you can do to reduce your risk. Approximately 21,560 new cases of esophageal cancer ― 17,030 in men and 4,530 in women ― will be diagnosed in the U.S. this year, and 16,120 people ― 12,920 men and 3,200 women ― will die from the disease, according to the American Cancer Society. Esophageal cancer usually begins in the cells… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - April 20, 2024 Category: Databases & Libraries Source Type: news
Neighborhood Disadvantage Tied to Shorter Breast Cancer-Specific Survival
FRIDAY, April 19, 2024 -- Neighborhood disadvantage is associated with shorter breast cancer-specific survival, according to a study published online April 18 in JAMA Network Open.Neha Goel, M.D., M.P.H., from the University of Miami Miller School... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 19, 2024 Category: Pharmaceuticals Source Type: news
NIH develops AI tool to better pair cancer patients with drugs
The proof-of-concept study published in Nature Cancer highlights how researchers are using tumor cells to predict whether patients will respond to specific drugs. (Source: mobihealthnews)
Source: mobihealthnews - April 19, 2024 Category: Information Technology Source Type: news
Academics + Pharma = Big Bucks; New CAR-T Warnings; Patients Seek Cancer Tests
(MedPage Today) -- Amid controversy and discussions about the high cost of cancer drugs, some academic medical centers profit handsomely from pharma-paid royalties on drugs developed with public funding. (Los Angeles Magazine)
The FDA has mandated... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - April 19, 2024 Category: Hematology Source Type: news
I was diagnosed with stage 3 colon cancer aged 34 despite being in best shape of my life - don't ignore the embarrassing symptom I did
Jelena Tompkins of Colorado was just 34 years old in 2016 when she noticed her gas smelled more foul than usual. She was diagnosed with stage three rectal cancer. (Source: the Mail online | Health)
Source: the Mail online | Health - April 19, 2024 Category: Consumer Health News Source Type: news
Alectinib Lands FDA Approval for Adjuvant Therapy in NSCLC
(MedPage Today) -- The FDA extended indications for alectinib (Alecensa) to include adjuvant treatment for ALK-positive non-small cell lung cancer (NSCLC), the first such approval for an ALK inhibitor.
The approval stipulates use of alectinib... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - April 19, 2024 Category: Hematology Source Type: news
Scientists reveal if your body shape puts you at risk of colorectal cancer
Your body shape could be putting you at a higher risk of colorectal cancer, scientists have warned. Colorectal cancer is the second-leading cause of cancer deaths in the United States, according to the American Cancer Society, with roughly 150,000 new cases projected for 2024. Overall, the…#bmi #heinzfreisling #scienceadvances #freisling #ukbiobank #obese (Source: Reuters: Health)
Source: Reuters: Health - April 19, 2024 Category: Consumer Health News Source Type: news
ICI Tx in MS Patients With Comorbid Cancer: Reassuring Data ICI Tx in MS Patients With Comorbid Cancer: Reassuring Data
There is no increased relapse risk in patients with multiple sclerosis and comorbid cancer who are taking checkpoint inhibitor therapy, results of a small study suggest.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 19, 2024 Category: Cancer & Oncology Tags: Neurology & Neurosurgery News Source Type: news
Some Older Women Need Extra Breast Scans. Why Won ’t Medicare Pay?
Mammography can miss tumors in women with dense breasts, so their doctors often include ultrasound or M.R.I. scans. Patients often wind up paying the bill. (Source: NYT Health)
Source: NYT Health - April 19, 2024 Category: Consumer Health News Authors: Roni Caryn Rabin Tags: your-feed-science Breast Cancer Tests (Medical) Mammography Women and Girls Medicare Disease Rates Ultrasonic Imaging and Sonograms Tumors Preventive Medicine Centers for Medicare and Medicaid Services Source Type: news
Spark co-founder, Harvard professor launch Watertown biotech with $54M
The Watertown startup has an ambitious goal of developing vaccines that provide lifelong protection from cancer and infectious diseases. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 19, 2024 Category: Pharmaceuticals Authors: Hannah Green Source Type: news
Evergreen Theragnostics raises $26M
Evergreen Theragnostics has raised $26 million in capital through its existing shareholders and new backers Petrichor and LIFTT.
With the funding, the Springfield, NJ-based company plans to advance commercialization of its Ga-68 DOTATOC diagnostic kit, and further its theranostic pair, EVG-321, into clinical trials. Evergreen also intends to expand its capabilities as a contract development and manufacturing organization (CDMO).
Stefano Buono, chairman of LIFTT and founder and former CEO of Advanced Accelerator Applications, noted the funding is based on optimism around rapidly advancing radioligand therapies.
Evergreen...
Source: AuntMinnie.com Headlines - April 19, 2024 Category: Radiology Authors: AuntMinnie.com staff writers Tags: Industry News Nuclear Radiology Radiation Oncology Source Type: news
CancerIQ Launches Research Initiative to Quantify Downstream Value of Digitally Enabled Cancer Risk Programs
The "Validating Applications for Long-term Utility and Enhanced ROI" (VALUE) in Cancer Risk Programs Study aims to bring together health systems from across the country to advance understanding of the system-level financial value of genetics and genomics. CHICAGO, April 19, 2024... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - April 19, 2024 Category: Pharmaceuticals Tags: PDT Source Type: news
Mortality Down for Rectal Cancer Surgery at NAPRC-Accredited Hospitals
FRIDAY, April 19, 2024 -- National Accreditation Program for Rectal Cancer (NAPRC)-accredited hospitals have lower risk-adjusted mortality and morbidity for patients undergoing major rectal cancer surgery, according to a study published online March... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 19, 2024 Category: Pharmaceuticals Source Type: news
New Screening Protocol May Improve Prostate Cancer Detection New Screening Protocol May Improve Prostate Cancer Detection
However, it ' s not yet clear whether a new three-phase screening intervention, which incorporates PSA test, a four-kallikrein panel, and MRI, will reduce prostate cancer mortality.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 19, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Clinical Summary Source Type: news
FDA approves Roche ’s Alecensa as the first adjuvant treatment for people with ALK-positive early-stage lung cancer
Approval based on Phase III ALINA study showing Alecensa reduced the risk of disease recurrence or death by an unprecedented 76% in people with ALK-positive early-stage resected non-small cell lung cancer (NSCLC)1This approval helps address an urgent unmet need, with abouthalf of people living with early-stage NSCLC experiencing disease recurrence following surgery, despite adjuvant chemotherapy2TheNational Comprehensive Cancer Network ® (NCCN®)Guidelines recommend routine testing for ALK, EGFR and PD-L1 biomarkers in people with early-stage NSCLC to inform adjuvant therapy selectionBasel, 19 April 2024 - Roche (SIX: RO,...
Source: Roche Investor Update - April 19, 2024 Category: Pharmaceuticals Source Type: news
